ECSP099040A - Nuevos análogos de piridina - Google Patents
Nuevos análogos de piridinaInfo
- Publication number
- ECSP099040A ECSP099040A EC2009009040A ECSP099040A ECSP099040A EC SP099040 A ECSP099040 A EC SP099040A EC 2009009040 A EC2009009040 A EC 2009009040A EC SP099040 A ECSP099040 A EC SP099040A EC SP099040 A ECSP099040 A EC SP099040A
- Authority
- EC
- Ecuador
- Prior art keywords
- analogs
- piridine
- new
- medicaments
- usefulness
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
La presente invención se relaciona con ciertos nuevos análogos de piridina de la fórmula ( I ) con procesos para preparar tales compuestos, con su utilidad en medicina en general y especialmente como inhibidores de P2Y12 y como agentes antitrombóticos etc., con su uso como medicamentos en enfermedades cardiovasculares así como con las composiciones farmacéuticas que los contienen.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0601463 | 2006-07-04 | ||
SE0602091 | 2006-10-04 | ||
SE0700059 | 2007-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099040A true ECSP099040A (es) | 2009-02-27 |
Family
ID=38894825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009040A ECSP099040A (es) | 2006-07-04 | 2009-01-07 | Nuevos análogos de piridina |
Country Status (16)
Country | Link |
---|---|
US (2) | US20080039437A1 (es) |
EP (1) | EP2044050A1 (es) |
JP (1) | JP2009542644A (es) |
KR (1) | KR20090034935A (es) |
AR (1) | AR061805A1 (es) |
AU (1) | AU2007270086A1 (es) |
BR (1) | BRPI0713967A2 (es) |
CA (1) | CA2655633A1 (es) |
CL (1) | CL2007001937A1 (es) |
EC (1) | ECSP099040A (es) |
IL (1) | IL195982A0 (es) |
MX (1) | MX2008016548A (es) |
NO (1) | NO20085215L (es) |
TW (1) | TW200811133A (es) |
UY (1) | UY30457A1 (es) |
WO (1) | WO2008004946A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008016551A (es) * | 2006-07-04 | 2009-02-06 | Astrazeneca Ab | Analogos de piridina nuevos. |
AR064865A1 (es) * | 2007-07-13 | 2009-04-29 | Astrazeneca Ab | Derivados de piridina antagonistas de p2y12 |
AR072697A1 (es) * | 2008-07-07 | 2010-09-15 | Astrazeneca Ab | Compuestos de piridina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastorno de agregacion plaquetaria |
EP2750676B1 (en) | 2011-08-30 | 2018-01-10 | University of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
DK1257550T3 (da) * | 2000-02-04 | 2006-03-27 | Portola Pharm Inc | Blodplade-ADP-receptor-inhibitor |
US7018985B1 (en) * | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
FR2820057A1 (fr) * | 2001-01-30 | 2002-08-02 | Ct De Transfert De Technologie | Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane |
KR20060041309A (ko) * | 2003-08-13 | 2006-05-11 | 다케다 야쿠힌 고교 가부시키가이샤 | 4-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도 |
EP1667989A4 (en) * | 2003-10-03 | 2008-08-20 | Portola Pharm Inc | SUBSTITUTED ISOQUINOLEINONES |
US7749981B2 (en) * | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
US7504497B2 (en) * | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
US7335648B2 (en) * | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
EA200700117A1 (ru) * | 2004-06-24 | 2007-06-29 | Инсайт Корпорейшн | N-замещенные пиперидины и их применение в качестве фармацевтических препаратов |
US20090227555A2 (en) * | 2005-01-06 | 2009-09-10 | Astrazeneca Ab | Novel Pyridine Compounds |
AU2007270082A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | New pyridine analogues |
MX2008016551A (es) * | 2006-07-04 | 2009-02-06 | Astrazeneca Ab | Analogos de piridina nuevos. |
AU2007270083A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | New pyridine analogues |
-
2007
- 2007-06-28 TW TW096123504A patent/TW200811133A/zh unknown
- 2007-07-02 CA CA002655633A patent/CA2655633A1/en not_active Abandoned
- 2007-07-02 US US11/772,269 patent/US20080039437A1/en not_active Abandoned
- 2007-07-02 AU AU2007270086A patent/AU2007270086A1/en not_active Abandoned
- 2007-07-02 MX MX2008016548A patent/MX2008016548A/es not_active Application Discontinuation
- 2007-07-02 US US12/307,277 patent/US20100069350A1/en not_active Abandoned
- 2007-07-02 KR KR1020097001915A patent/KR20090034935A/ko not_active Application Discontinuation
- 2007-07-02 WO PCT/SE2007/000646 patent/WO2008004946A1/en active Application Filing
- 2007-07-02 EP EP07748305A patent/EP2044050A1/en not_active Withdrawn
- 2007-07-02 JP JP2009518051A patent/JP2009542644A/ja active Pending
- 2007-07-02 BR BRPI0713967-5A patent/BRPI0713967A2/pt not_active Application Discontinuation
- 2007-07-03 AR ARP070102973A patent/AR061805A1/es unknown
- 2007-07-03 CL CL200701937A patent/CL2007001937A1/es unknown
- 2007-07-03 UY UY30457A patent/UY30457A1/es not_active Application Discontinuation
-
2008
- 2008-12-15 NO NO20085215A patent/NO20085215L/no not_active Application Discontinuation
- 2008-12-16 IL IL195982A patent/IL195982A0/en unknown
-
2009
- 2009-01-07 EC EC2009009040A patent/ECSP099040A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2009542644A (ja) | 2009-12-03 |
NO20085215L (no) | 2009-01-13 |
CA2655633A1 (en) | 2008-01-10 |
UY30457A1 (es) | 2008-02-29 |
EP2044050A1 (en) | 2009-04-08 |
WO2008004946A1 (en) | 2008-01-10 |
KR20090034935A (ko) | 2009-04-08 |
TW200811133A (en) | 2008-03-01 |
AU2007270086A1 (en) | 2008-01-10 |
US20100069350A1 (en) | 2010-03-18 |
CL2007001937A1 (es) | 2008-07-25 |
MX2008016548A (es) | 2009-02-12 |
US20080039437A1 (en) | 2008-02-14 |
AR061805A1 (es) | 2008-09-24 |
IL195982A0 (en) | 2009-09-01 |
BRPI0713967A2 (pt) | 2012-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP088975A (es) | Nuevos análagos de piridina | |
UY29325A1 (es) | Nuevos derivados de 2 - amino-piridina | |
UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
UY29667A1 (es) | Nuevos compuestos de piridina, composiciones farmaccuticas que los contienen, procedimientos de preparacinn y aplicaciones | |
UY30444A1 (es) | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. | |
BR112013023876A2 (pt) | derivados de pirroltriazinona como inibidores de pi3k | |
ECSP099750A (es) | Imidazoquinolinas con propiedades inmunomoduladoras | |
ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
CL2007001166A1 (es) | Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica | |
DOP2011000361A (es) | Nuevos derivados de pirimidina y sus usos en el tratamiento del cancer y otras enfermedades | |
CL2007001167A1 (es) | Compuestos derivados de pirimidina condensada, inhibidores de p13-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicionfarmaceutica. | |
CU20110204A7 (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CL2010001348A1 (es) | Compuestos derivados de 1-oxo-2,3-dihidro-1h-isoindolin-5-il)-isoxazol-3-carboxamida, potenciadores de los mglur2; composicion farmaceutica; y su uso para aliviar los sintomas o disminuir la aparicion de los sintomas de ezquizofrenia o ansiedad. | |
ECSP077271A (es) | Derivados de pirimidina | |
UY29003A1 (es) | Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
ECSP077259A (es) | Derivados de pirimidina | |
ECSP099481A (es) | Compuestos de piridina y su uso como antagonistas de p2y12 | |
UY30856A1 (es) | Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
ECSP099425A (es) | Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2 | |
UY31905A (es) | Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
UY30865A1 (es) | Nuevos analogos de piridina x 161 | |
UY30868A1 (es) | Nuevos compuestos de piridina, composiciones farmacéuticas conteniéndolas y aplicaciones. | |
ECSP099040A (es) | Nuevos análogos de piridina | |
UY30867A1 (es) | Nuevos analogos de piridina vii 543 |